Kinsenoside Protects Against Radiation-Induced Liver Fibrosis via Downregulating Connective Tissue Growth Factor Through TGF-β1 Signaling

Radiation-induced liver fibrosis (RILF) is a serious complication of the radiotherapy of liver cancer, which lacks effective prevention and treatment measures. Kinsenoside (KD) is a monomeric glycoside isolated from Anoectochilus roxburghii, which has been reported to show protective effect on the early progression of liver fibrosis. However, the role of KD in affecting RILF remains unknown. Here, we found that KD alleviated RILF via downregulating connective tissue growth factor (CTGF) through TGF-β1 signaling. Sprague-Dawley rats were administered with 20 mg/kg KD per day for 8 weeks after a single 30Gy irradiation on the right part of liver, and tumor-bearing nude mice were administered with 30 mg/kg KD per day after a single fraction of 10Gy on the tumor inoculation site. Twenty-four weeks postirradiation, we found that the administration of KD after irradiation resulted in decreased expression of α-SMA and fibronectin in the liver tissue while had no adverse effect on the tumor radiotherapy. Besides, KD inhibited the activation of hepatic stellate cells (HSCs) postirradiation via targeting CTGF as indicated by the transcriptome sequencing. Results of the pathway enrichment and immunohistochemistry suggested that KD reduced the expression of TGF-β1 protein after radiotherapy, and exogenous TGF-β1 induced HSCs to produce α-SMA and other fibrosis-related proteins. The content of activated TGF-β1 in the supernatant decreased after treatment with KD. In addition, KD inhibited the expression of the fibrosis-related proteins by regulating the TGF-β1/Smad/CTGF pathway, resulting in the intervention of liver fibrosis. In conclusion, this study revealed that KD alleviated RILF through the regulation of TGFβ1/Smad/CTGF pathway with no side effects on the tumor therapy. KD, in combination with blocking the TGF-β1 pathway and CTGF molecule or not, may become the innovative and effective treatment for RILF.

[1]  Qian-qian Xu,et al.  Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis , 2021, Pharmaceuticals.

[2]  D. Brenner,et al.  Molecular and cellular mechanisms of liver fibrosis and its regression , 2020, Nature Reviews Gastroenterology & Hepatology.

[3]  T. Taguchi,et al.  Peroxisome Proliferator-Activated Receptor Gamma Agonist Attenuates Liver Fibrosis by Several Fibrogenic Pathways in an Animal Model of Cholestatic Fibrosis , 2020, Pediatric gastroenterology, hepatology & nutrition.

[4]  E. Crouchet,et al.  Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives , 2020, Cells.

[5]  Yuhan Chen,et al.  Circular RNA RSF1 promotes inflammatory and fibrotic phenotypes of irradiated hepatic stellate cell by modulating miR‐146a‐5p , 2020, Journal of cellular physiology.

[6]  C. Meyer,et al.  TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019 , 2019, Cells.

[7]  J. Cheng,et al.  MicroRNA-146a-5p Attenuates Fibrosis-related Molecules in Irradiated and TGF-beta1-Treated Human Hepatic Stellate Cells by Regulating PTPRA-SRC Signaling , 2019, Radiation Research.

[8]  Hae-June Lee,et al.  Plasma Fibrinogen-Like 1 as a Potential Biomarker for Radiation-Induced Liver Injury , 2019, Cells.

[9]  Yingqun Zhou,et al.  Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways , 2019, Mediators of inflammation.

[10]  Daming Gao,et al.  TGF-β1/p65/MAT2A pathway regulates liver fibrogenesis via intracellular SAM , 2019, EBioMedicine.

[11]  R. Derynck,et al.  Specificity, versatility, and control of TGF-β family signaling , 2019, Science Signaling.

[12]  K. Shokat,et al.  Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition , 2019, Science Signaling.

[13]  J. Cheng,et al.  Proteomic Profiling of Human Hepatic Stellate Cell Line LX2 Responses to Irradiation and TGF-β1. , 2018, Journal of proteome research.

[14]  G. Giannelli,et al.  TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives , 2018, Seminars in Liver Disease.

[15]  C. Shi,et al.  Using IVIM-MRI and R2⁎ Mapping to Differentiate Early Stage Liver Fibrosis in a Rat Model of Radiation-Induced Liver Fibrosis , 2018, BioMed research international.

[16]  Xue-ke Zhao,et al.  Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway , 2018, Drug design, development and therapy.

[17]  Wei Wang,et al.  Rapamycin Upregulates Connective Tissue Growth Factor Expression in Hepatic Progenitor Cells Through TGF-β-Smad2 Dependent Signaling , 2018, Front. Pharmacol..

[18]  R. Goldschmeding,et al.  Connective tissue growth factor (CTGF) from basics to clinics. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[19]  H. Eguchi,et al.  CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression. , 2018, Cancer research.

[20]  B. Hinz,et al.  The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix , 2018, Journal of Cell Science.

[21]  Changxing Qi,et al.  Kinsenoside: A Promising Bioactive Compound from Anoectochilus Species , 2018, Current medical science.

[22]  Fachao Zhi,et al.  Baicalin inhibits PDGF-BB-induced hepatic stellate cell proliferation, apoptosis, invasion, migration and activation via the miR-3595/ACSL4 axis , 2018, International journal of molecular medicine.

[23]  Liuyi Dong,et al.  Paeoniflorin exerts protective effect on radiation-induced hepatic fibrosis in rats via TGF-β1/Smads signaling pathway. , 2018, American journal of translational research.

[24]  J. Ladero,et al.  Liver fibrosis. , 2018, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[25]  Wen-hui Zhou,et al.  Pathological process of liver sinusoidal endothelial cells in liver diseases , 2017, World journal of gastroenterology.

[26]  L. Dawson,et al.  Radiation-Induced Liver Toxicity. , 2017, Seminars in radiation oncology.

[27]  Zhi-feng Wu,et al.  Microarray profiling of circular RNAs and the potential regulatory role of hsa_circ_0071410 in the activated human hepatic stellate cell induced by irradiation. , 2017, Gene.

[28]  Zhang Ailian,et al.  Anoectochilus roxburghii: A review of its phytochemistry, pharmacology, and clinical applications. , 2017 .

[29]  S. Glaser,et al.  Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells , 2017, Hepatology.

[30]  Alicia J. Zollinger,et al.  Fibronectin, the extracellular glue. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[31]  Jieun Kim,et al.  Radiation-induced liver disease: current understanding and future perspectives , 2017, Experimental &Molecular Medicine.

[32]  S. Galal,et al.  Diosmin attenuates radiation-induced hepatic fibrosis by boosting PPAR-γ expression and hampering miR-17-5p-activated canonical Wnt-β-catenin signaling. , 2017, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[33]  E. Harris,et al.  SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis , 2017, BioMed research international.

[34]  J. Rosenbloom,et al.  Human Fibrotic Diseases: Current Challenges in Fibrosis Research. , 2017, Methods in molecular biology.

[35]  A. Hinck,et al.  Structural Biology and Evolution of the TGF-β Family. , 2016, Cold Spring Harbor perspectives in biology.

[36]  Junjun Liu,et al.  Effects of kinsenoside, a potential immunosuppressive drug for autoimmune hepatitis, on dendritic cells/CD8+T cells communication in mice , 2016, Hepatology.

[37]  R. Derynck,et al.  The Discovery and Early Days of TGF-β: A Historical Perspective. , 2016, Cold Spring Harbor perspectives in biology.

[38]  F. Tacke,et al.  Liver Fibrosis: From Pathogenesis to Novel Therapies , 2016, Digestive Diseases.

[39]  G. Gambaro,et al.  Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation , 2016, Journal of Nephrology.

[40]  Wei Wang,et al.  Activin A-Smad Signaling Mediates Connective Tissue Growth Factor Synthesis in Liver Progenitor Cells , 2016, International journal of molecular sciences.

[41]  Lei Zhang,et al.  TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis , 2016, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[42]  R. Weiskirchen.  Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step , 2016, Front. Pharmacol..

[43]  Jinyong Peng,et al.  Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway , 2015, Scientific Reports.

[44]  S. Dooley,et al.  TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis: Updated , 2015, Current Pathobiology Reports.

[45]  Fei Li,et al.  Rapamycin increases CCN2 expression of lung fibroblasts via phosphoinositide 3-kinase , 2015, Laboratory Investigation.

[46]  Yixing Chen,et al.  Mesenchymal stem cell–conditioned medium prevents radiation-induced liver injury by inhibiting inflammation and protecting sinusoidal endothelial cells , 2015, Journal of radiation research.

[47]  H. Atta.  Reversibility and heritability of liver fibrosis: Implications for research and therapy. , 2015, World journal of gastroenterology.

[48]  Wei Cheng,et al.  Molecular responses of radiation-induced liver damage in rats , 2014, Molecular medicine reports.

[49]  B. Bilińska,et al.  Hydroxyflutamide alters the characteristics of live boar spermatozoa. , 2014, Theriogenology.

[50]  W. Kuo,et al.  NAD+ protects against EAE by regulating CD4+ T-cell differentiation , 2014, Nature Communications.

[51]  U. Das,et al.  Effect of yellow capsicum extract on proliferation and differentiation of 3T3-L1 preadipocytes. , 2014, Nutrition.

[52]  S. Forbes,et al.  Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. , 2014, Gastroenterology.

[53]  Sang‐wook Lee,et al.  Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters , 2013, Radiation Oncology.

[54]  Jeongeun Hyun,et al.  Potential Role of Hedgehog Pathway in Liver Response to Radiation , 2013, PloS one.

[55]  Jun Wei,et al.  MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[56]  B. Kavanagh,et al.  Hepatic radiation toxicity: avoidance and amelioration. , 2011, Seminars in radiation oncology.

[57]  S. Friedman,et al.  Mechanisms of hepatic fibrogenesis. , 2011, Best practice & research. Clinical gastroenterology.

[58]  Jian Zhou,et al.  Radiation-induced liver fibrosis is mitigated by gene therapy inhibiting transforming growth factor-β signaling in the rat. , 2010, International journal of radiation oncology, biology, physics.

[59]  M. Pekalski,et al.  Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease , 2008, Laboratory Investigation.

[60]  C. J. Marek,et al.  Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. , 2005, Gastroenterology.

[61]  S. Friedman,et al.  Transcriptional Activation of Transforming Growth Factor β1 and Its Receptors by the Kruppel-like Factor Zf9/Core Promoter-binding Protein and Sp1 , 1998, The Journal of Biological Chemistry.

[62]  P. Bedossa,et al.  An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.